Oleuropein as An Effective Suppressor of Inflammation and MicroRNA-146a Expression in Patients with Rheumatoid

Hanieh Mahi1, Zahra Yousefi2, Fatemeh Toufan1

  • 1Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.

Cell Journal
|August 6, 2023
PubMed
Abstract

Insights

MicroRNA-146a shows high sensitivity and specificity for rheumatoid arthritis (RA) diagnosis. Oleuropein (OLEU) treatment reduced inflammation by regulating miRNA-146a and tumor necrosis factor-alpha (TNF-α) in RA patients.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and potential organ damage.
  • MicroRNA-146a (miRNA-146a) has been implicated in the pathogenesis of RA.
  • Oleuropein (OLEU), a natural compound, has demonstrated anti-inflammatory effects and the ability to modulate microRNA expression in various conditions.

Purpose of the Study:

  • To assess the diagnostic accuracy of miRNA-146a in rheumatoid arthritis.
  • To investigate the therapeutic potential of oleuropein (OLEU) in RA.
  • To determine the effects of OLEU on miRNA-146a and tumor necrosis factor-alpha (TNF-α) levels in RA patients.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from RA patients (n=45) and healthy controls (n=30) were analyzed.
  • PBMCs were treated with varying concentrations of OLEU.
  • Levels of TNF-α, anti-citrullinated protein, and miRNA-146a were quantified using ELISA and real-time PCR.
  • Receiver operating characteristic (ROC) curve analysis was employed to evaluate miRNA-146a's diagnostic performance.

Main Results:

  • miRNA-146a expression positively correlated with C-reactive protein (CRP) and rheumatoid factor (RF) in RA patients.
  • OLEU treatment led to decreased levels of TNF-α and miRNA-146a in PBMCs compared to untreated cells.
  • ROC analysis indicated 85% sensitivity and 100% specificity for miRNA-146a in diagnosing RA.

Conclusions:

  • miRNA-146a serves as a valuable biomarker for the diagnosis of rheumatoid arthritis, aiding in early detection.
  • Oleuropein (OLEU) demonstrates potential in suppressing RA-associated inflammation through miRNA-146a regulation.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
357
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.6K